Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Navigare necessere est (CROSBI ID 116366)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Kraljević, Sandra ; Pavelić, Krešimir Navigare necessere est // EMBO reports, 6 (2005), 8; 695-700-x

Podaci o odgovornosti

Kraljević, Sandra ; Pavelić, Krešimir

engleski

Navigare necessere est

Nanotechnology supports and enhances advances in genomics and proteomics. Specifically, it offers many interesting possibilities for improving drug delivery. The rapid progress of nanotechnology-based applications in medicine is due to the huge interest from therapeutic and diagnostic companies, which have already introduced many nanotechnology-based devices to everyday practice, among them new drug-delivery systems. Future research should further improve their targeting properties, given that one of the most important problems in medicine is the controlled and exact delivery of a drug to diseased tissue. However, the promising solutions offered by nanotechnology pose some inevitable questions. We still do not know whether organic and inorganic nanoparticles, once they have entered the body, can cause damage to other tissues. Additionally, we need new safety standards as the novel and unexplored characteristics of nanoscale materials demand appropriate quality-control measures. The further development of new strategies in drug delivery depends largely on the establishment of such standards and their subsequent implementation in research and manufacturing.

navigation; homing proteins; delivery; gene therapy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

6 (8)

2005.

695-700-x

objavljeno

1469-221X

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost